Smoking Behavior in Liver Transplant Recipients
Open accessThe DOI matches its Crossref record.
Abstract
Long-term morbidity and survival after orthotopic liver transplantation (OLT) are to a large degree determined by cardiovascular disease and cancer. Tobacco use is a well-known risk factor for both. The aim of this study was to examine smoking behavior before and after OLT and to define groups at risk for resuming tobacco use after OLT. In addition, we looked for a relation between smoking and morbidity after OLT. All 401 adult patients with a follow-up of at least 2 years after OLT were included. Data were collected from the charts. A questionnaire about smoking habits at 4 time points before and after OLT was sent to all 326 patients alive, and 301 (92%) patients responded. Both before and after OLT, 53% of patients never used tobacco, and around 17% were active smokers. Of the active smokers during the evaluation for OLT, almost one-third succeeded in cessation, often during the waiting time for OLT. Twelve percent of former smokers restarted smoking, mainly after OLT. Tobacco use was the highest in patients with alcoholic liver disease (52% were active smokers before OLT, and 44% were after OLT) and the lowest in patients with primary sclerosing cholangitis (1.4% were active smokers before OLT). At 10 years, the cumulative rate of malignancies was 12.7% in active smokers versus 2.1% in nonsmokers (P = 0.019). No effect on skin cancer or cardiovascular disease was found. In conclusion, smoking is a serious problem after OLT and increases the risk for malignancy. Prevention programs should focus not only on active smokers but also on former smokers. Liver Transpl 15: 648–655, 2009. © 2009 AASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
“Pre- and post-transplant smoking rates are high and cause significant morbidity and mortality due to cardiovascular events [143], increased incidence of hepatic artery thrombosis [144] and increased incidence of malignancies such as oropharyngeal [145].”
BackgroundMartin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., Sanchez, W., & Gores, G. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.070 · Cited by 268
Duerinckx, N., Burkhalter, H., Engberg, S. J., Kirsch, M., Klem, M.-L., Sereika, S. M., De Simone, P., De Geest, S., & Dobbels, F. (2016) · Transplantation · doi:10.1097/tp.0000000000001335 · Cited by 68
Kim, D.-S., Yoon, Y.-I., Kim, B. K., Choudhury, A., Kulkarni, A., Park, J. Y., Kim, J., Sinn, D. H., Joo, D. J., Choi, Y., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10629-3 · Cited by 47
Hofmann, P., Benden, C., Kohler, M., & Schuurmans, M. M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.16 · Cited by 37
“While an increasing number of studies have shown the carcinogenic adverse effects of smoking in liver transplant recipients, clinical trials regarding smoking resumption in heart or lung recipients, however, have been controversial (Table 2) (34-36).”
Background
Metadata
- Authors
- van der Heide, F., Dijkstra, G., Porte, R. J., Kleibeuker, J. H., & Haagsma, E. B.
- Venue
- Liver Transplantation
- Published
- 2009-06
- Volume
- 15
- Issue
- 6
- Pages
- 648-655
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2099341575
- Cited by
- 95
- References
- 0
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.